关键词: Olfactory neuroblastoma cancer of the head and neck carbon ion radiotherapy multicenter study radiotherapy

Mesh : Adult Aged Disease-Free Survival Dose Fractionation, Radiation Esthesioneuroblastoma, Olfactory / radiotherapy Female Heavy Ion Radiotherapy / adverse effects methods Humans Male Middle Aged Mucositis / etiology Nasal Cavity / pathology radiation effects Nose Neoplasms / radiotherapy Optic Nerve Diseases / etiology Retrospective Studies Treatment Outcome

来  源:   DOI:10.21873/anticanres.12399

Abstract:
The purpose was to evaluate efficacy and safety of carbon ion radiotherapy (C-ion RT) in patients with locally advanced olfactory neuroblastomas (ONBs). This study was a sub-analysis of the Japan Carbon-Ion Radiation Oncology Study Group Study (1402 HN, UMIN000024473). Clinical data of T4 ONBs treated with C-ion RT at four Institutions between November 2003 and December 2014 were retrospectively reviewed. Twenty-one patients underwent C-ion RT. Seven patients had T4a and 14 had T4b tumours without cervical node metastases. The median follow-up period was 39 (range=5-111) months. The 3-year overall survival and local control rates were 88.4% and 83.0%, respectively. Grade 4 late toxicity was observed in three patients, including ipsilateral optic nerve disorder (n=2) and ipsilateral retinopathy (n=1). C-Ion RT is effective and can be a curative modality for T4 ONBs. Prospective multicenter studies are warranted to confirm these findings.
摘要:
暂无翻译
公众号